Article
MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSC
2022-10-12
Abstract excerpt
<title>Abstract</title> <p>The significance of MYL2 as a possible HNSC treatment gene is unknown, the purpose of this study was to determine the exact involvement of MYL2 in HNSC.The Tumor Immune Estimate Resource (TIMER), UALCAN, The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases were used to assess MYL2 mRNA and protein expression levels in HNSC. Experimental tests, including immunohist...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 354b3368-3818-5f7f-af80-044044994c55
- DOI
- 10.21203/rs.3.rs-2142569/v1
